PhaseBio Pharmaceuticals, Inc. (PHAS)
Operating Income
$29.35M
TTM · Period ending: · USD
PHAS Operating Income
Latest reported$29.35Mperiod ending
Latest reported$29.35Mperiod ending
PHAS TTM Operating Income (-$11.33M → $29.35M)
TTM operating income
High-resolution chart · PNG
PHAS operating income history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Income (USD) |
|---|---|
| 29,351,582 | |
| 24,847,582 | |
| 10,193,582 | |
| -101,254,000 | |
| -93,170,000 | |
| -96,215,000 | |
| -84,856,000 | |
| -70,158,000 | |
| -61,256,000 | |
| -46,640,000 | |
| -39,736,000 | |
| -36,116,000 | |
| -29,525,000 | |
| -24,150,000 | |
| -19,644,000 | |
| -14,435,000 | |
| -11,331,000 |